Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27
- PMID: 6571696
- DOI: 10.1038/304547a0
Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27
Abstract
Vasoactive intestinal polypeptide (VIP), a 28-amino acid peptide originally isolated from porcine duodenum, is present not only in gastrointestinal tissues but also in neural tissues, possibly as a neurotransmitter, and exhibits a wide range of biological actions (for example, relaxation of smooth muscle, stimulation of intestinal water and electrolyte secretion and release of insulin, glucagon and several anterior pituitary hormones). As the structure of porcine and bovine VIP shows several similarities to those of mammalian glucagon, secretin and gastric inhibitory peptide (GIP), VIP is considered to be a member of the glucagon-secretin family. Recently, we have found that VIP is synthesized from a precursor, pro-VIP (molecular weight (Mr) 17,500), in human neuroblastoma cells and that the primary translation product of the mRNA encoding VIP is prepro-VIP (Mr 20,000). In an attempt to elucidate the primary structure of the precursor, we have now cloned the DNA sequence complementary to the mRNA coding for human VIP and analysed the nucleotide sequence. The entire amino acid sequence of the precursor, deduced from the nucleotide sequence, indicates that the precursor protein contains not only VIP but also a novel peptide of 27 amino acids. The peptide, designated PHM-27, differs by only 2 amino acids from PHI-27, a peptide recently isolated from porcine intestine, and is also closely related in sequence to VIP.
Similar articles
-
Tissue-specific alternative splicing of turkey preprovasoactive intestinal peptide messenger ribonucleic acid, its regulation, and correlation with prolactin secretion.Endocrinology. 1995 Jun;136(6):2602-10. doi: 10.1210/endo.136.6.7750483. Endocrinology. 1995. PMID: 7750483
-
Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat.FEBS Lett. 1985 Apr 8;183(1):55-9. doi: 10.1016/0014-5793(85)80953-4. FEBS Lett. 1985. PMID: 3838518
-
Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.Ann N Y Acad Sci. 1988;527:87-102. doi: 10.1111/j.1749-6632.1988.tb26975.x. Ann N Y Acad Sci. 1988. PMID: 2839091
-
Vasoactive intestinal peptide and anterior pituitary function.Clin Endocrinol (Oxf). 1988 Dec;29(6):677-88. doi: 10.1111/j.1365-2265.1988.tb03716.x. Clin Endocrinol (Oxf). 1988. PMID: 3076850 Review.
-
[Pituitary adenylate cyclase-activating polypeptide].Ann Endocrinol (Paris). 1998 Dec;59(5):364-405. Ann Endocrinol (Paris). 1998. PMID: 9949891 Review. French.
Cited by
-
Gene transfer into the nervous system.Mol Neurobiol. 1987 Winter;1(4):339-71. doi: 10.1007/BF02935741. Mol Neurobiol. 1987. PMID: 3077063 Review. No abstract available.
-
Peptidergic nerve elements in three developmental stages of the tetraphyllidean tapeworm Trilocularia acanthiaevulgaris. An immunocytochemical study.Parasitol Res. 1990;76(6):497-508. doi: 10.1007/BF00931055. Parasitol Res. 1990. PMID: 1696377
-
Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.Dig Dis Sci. 1988 Apr;33(4):423-8. doi: 10.1007/BF01536026. Dig Dis Sci. 1988. PMID: 3349889
-
Vasoactive intestinal peptide.J Endocrinol Invest. 1986 Apr;9(2):191-200. doi: 10.1007/BF03348097. J Endocrinol Invest. 1986. PMID: 2872248 Review. No abstract available.
-
Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans.J Physiol. 2003 Oct 1;552(Pt 1):223-32. doi: 10.1113/jphysiol.2003.042135. Epub 2003 Jul 7. J Physiol. 2003. PMID: 12847205 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials